In vitro potency assays for immune cell-mediated killing with the Maestro Z

28 Jan 2022

Immunotherapy harnesses the power of the innate and adaptive immune system in various ways to seek out and attack cancer. Current immunotherapeutic approaches include monoclonal antibodies that mark cancer cells for improved immune cell recognition and/or recruit immune cells to the site of malignancies, oncolytic viruses that infect and kill cancer cells, and more. In this application note, find out how the Maestro Z is used for immune cell-mediated killing in in-vitro potency assays

Links

Tags